when were glp-1 agonists approved for weight loss Weight-loss drugs such as Ozempic in the headlines a lot in 2025 – and patent protections these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ The expanding landscape of GLP-1

Like GLP-1, GIP travels through your bloodstream and activates specific GIP receptors in various organs

GLP-1 associated hair loss is unique in that the continued weight loss is a continued stressor,' said Jenni Holman, MD, FAAD, a diplomate of the American Academy of Dermatology

Panunzi S, Maltese S, De Gaetano A, Capristo E, Bornstein SR, Mingrone G

doi:10.1007/s001250051335 119

Vincenti, M

Drugs that target inflammation, synaptic dysfunction, insulin resistance, and oxidative stress, all of which lead to neuronal death and neurodegeneration, should also be considered for an effective therapeutic strategy for AD and PD